logo-loader
NASDAQ:SGNL

Signal Genetics

Receive alerts
Market:
NASDAQ
Market Cap:
-
Price
-
Change
-
52 weeks high
-
52 weeks low
-

In brief

Signal Genetics is a commercial stage, molecular diagnostic company helping physicians make better-informed decisions concerning the care of their patients suffering from multiple myeloma (MM) through our flagship product Myeloma Prognostic Risk Signature, or MyPRS®. Our mission is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.